These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5007444)

  • 1. Effect of hypocholesteremic drugs on tumor-bearing mice.
    Kabara JJ; Chapman BB; Borin BM
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):100-4. PubMed ID: 5007444
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of lipid biosynthesis.
    Dempsey ME
    Ann N Y Acad Sci; 1968 Mar; 148(3):631-46. PubMed ID: 4385358
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of a vertebrate hypocholesterolemic agent on sterol metabolism and development of Bombyx mori.
    Hikino H; Oizumi Y; Saito T; Nakamura E; Takemoto T
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):851-3. PubMed ID: 5045619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic study of a hypocholesteremic agent (MG. 46)].
    Nordmann J; Loiseau G; Berthe G; Lohier P; Truchaud M
    Therapie; 1972; 27(2):339-58. PubMed ID: 4673514
    [No Abstract]   [Full Text] [Related]  

  • 5. The hypocholesterolemic action of eritadenine in the rat.
    Takashima K; Izumi K; Iwai H; Takeyama S
    Atherosclerosis; 1973; 17(3):491-502. PubMed ID: 4736648
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteration of cellular and acellular alveolar and bronchiolar walls produced by hypocholesteremic drug AY9944.
    Kikkawa Y; Suzuki K
    Lab Invest; 1972 Apr; 26(4):441-7. PubMed ID: 4336541
    [No Abstract]   [Full Text] [Related]  

  • 8. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
    Maxwell RE; Nawrocki JW; Uhlendorf PD
    Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
    Kritchevsky D; Tepper SA; Czarnecki SK; Story JA
    Pharmacol Res Commun; 1979 Nov; 11(10):861-7. PubMed ID: 538065
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphochemical and biochemical principles of atherosclerosis pharmacotherapy].
    Godlewski HG
    Postepy Hig Med Dosw; 1977; 31(2):171-230. PubMed ID: 329244
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of cholesterol synthesis by beta-benzal butyric acid and derivatives.
    Porcellati G; Giorgini D; Toja E
    Lipids; 1969 May; 4(3):190-6. PubMed ID: 5785689
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
    Turley SD; Dietschy JM
    J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride].
    Marmo E; Imperatore AM; Caputi A; Cataldi S
    Farmaco Prat; 1971 Oct; 26(10):557-84. PubMed ID: 5157541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
    Kaiser W; Zöllner N
    Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of clofibrate].
    Lang PD
    Ther Ggw; 1975 Feb; 114(2):204-6, 208-10, 212-4. PubMed ID: 1118816
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeated estimation of liver cholesterol synthesis in vivo, using the inhibitor AY-9944.
    Horton BJ; Horton JD; Sabine JR
    Biochim Biophys Acta; 1971 Sep; 239(3):475-81. PubMed ID: 5113504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM
    Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.